CRISPR Therapeutics AG
NASDAQ:CRSP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
CH |
|
Solusi Bangun Indonesia Tbk PT
IDX:SMCB
|
ID |
|
Blue Hat Interactive Entertainment Technology
NASDAQ:BHAT
|
CN |
|
Cannabis Sativa Inc
OTC:CBDS
|
US |
|
Pacific Premier Bancorp Inc
NASDAQ:PPBI
|
US |
|
Domino's Pizza Enterprises Ltd
ASX:DMP
|
AU |
|
Sinar Mas Agro Resources and Technology Tbk PT
IDX:SMAR
|
ID |
|
Infineon Technologies AG
F:IFXA
|
DE |
|
Minotaur Exploration Ltd
ASX:MEP
|
AU |
|
Defiance Silver Corp
XTSX:DEF
|
CA |
|
Nearmap Ltd
ASX:NEA
|
AU |
|
S
|
Sena Development PCL
SET:SENA
|
TH |
|
Nippon Ichi Software Inc
TSE:3851
|
JP |
|
Prelude Therapeutics Inc
NASDAQ:PRLD
|
US |
|
E
|
Eneco Refresh Ltd
ASX:ERG
|
AU |
|
Marel hf
AEX:MAREL
|
IS |
|
Bank Raya Indonesia Tbk PT
IDX:AGRO
|
ID |
|
JetBlue Airways Corp
NASDAQ:JBLU
|
US |
|
Selaras Citra Nusantara Perkasa Tbk PT
IDX:SCNP
|
ID |
|
Dorman Products Inc
NASDAQ:DORM
|
US |
|
Scidev Ltd
ASX:SDV
|
AU |
|
Micropole SA
PAR:ALMIC
|
FR |
|
QuickFee Ltd
ASX:QFE
|
AU |
|
P
|
Petrolimex Installation No III JSC
VN:PEN
|
VN |
Shareholder Yield
Current shareholder yield for CRSP is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CRSP Price
CRISPR Therapeutics AG
| Average Annual Return | -15.65% |
| Standard Deviation of Annual Returns | 51.47% |
| Max Drawdown | -81% |
| Market Capitalization | 4.7B USD |
| Shares Outstanding | 95 990 000 |
| Percentage of Shares Shorted | 25.34% |
CRSP Return Decomposition
Main factors of price return
Stock Splits
CRSP's latest stock split occurred on Jul 19, 2016
The company executed a 333333-for-100000 stock split, meaning that for every 100000 shares held, investors received 333333 new shares.
The adjusted shares began trading on Jul 19, 2016. This was the only stock split in CRSP's history.
